会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • NOVEL N-(PYRIDYLCARBONYL)BENZAZEPINE DERIVATIVE AND INTERMEDIATE THEREFOR
    • 新型N-(吡咯烷基)苯并噻吩衍生物及其中间体
    • WO1994014796A1
    • 1994-07-07
    • PCT/JP1993001838
    • 1993-12-17
    • YAMANOUCHI PHARMACEUTICAL CO., LTD.MATSUMOTO, YuzoTANAKA, AkihiroMATSUHISA, AkiraKIKUCHI, KazumiSAKAMOTO, Ken-ichiroYATSU, TakeyukiYANAGISAWA, Isao
    • YAMANOUCHI PHARMACEUTICAL CO., LTD.
    • C07D401/06
    • C07D401/06
    • An N-(pyridylcarbonyl)benzazepine derivative represented by general formula (I) or a pharmaceutically acceptable salt thereof, useful for preventing and treating cardiac failure, hyponatremia, syndrome of inappropriate secretion of vasopressin (SIADH), hypertension, renal failure, edema, water metabolism disorder, and the like on the basis of arginine vasopressin receptor antagonism; and a benzazepinylcarbonylpyridine derivative represented by general formula (II) or a salt thereof, useful as an intermediate for the production of the compound (I) and so forth, wherein R represents hydrogen, lower alkyl, lower alkoxy, halogen, or phenyl which may be substituted by lower alkyl; X represents -NHCO- or -CON(R )-; n represents 0 or 1; and R represents hydrogen or (a) wherein R is as defined above, wherein n is as defined above; and Y represents COOH, activated carboxy, protected carboxy, or optionally protected HN(R )-.
    • 用于预防和治疗心力衰竭,低钠血症,加压素分泌不良综合征(SIADH),高血压,肾衰竭,水肿,水分的通式(I)表示的N-(吡啶基羰基)苯并氮杂衍生物或其药学上可接受的盐 代谢障碍等,基于精氨酸加压素受体拮抗作用; 和由通式(II)表示的苯并氮杂基羰基吡啶衍生物或其盐,可用作制备化合物(I)等的中间体,其中R表示氢,低级烷基,低级烷氧基,卤素或苯基, 被低级烷基取代; X表示-NHCO-或-CON(R 1) - ; n表示0或1; 并且R 1表示氢或(a)其中R如上定义,其中n如上所定义; 和Y代表COOH,活化的羧基,保护的羧基或任选被保护的HN(R 1) - 。